AI is changing how biological insight is generated, validated, and translated into therapeutic opportunity.
The Discovery Biology Stage focuses on how leading organisations are applying AI across early-stage drug discovery - from target identification and validation to hypothesis generation and decision-making under uncertainty.
Discover how teams are integrating multimodal data, embedding AI into discovery workflows, and accelerating biological understanding across increasingly complex R&D environments.
The organisations combining biological expertise with scalable AI capabilities will shape the future of drug discovery.